Diabetic kidney disease: a case for precision medicine? | Zendy

Gemma Currie | Zendy; Bill Mullen | Zendy; Christian Delles | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diabetic kidney disease: a case for precision medicine?

Author(s) -

Gemma Currie,

Bill Mullen,

Christian Delles

Publication year - 2016

Publication title -

the biochemist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.126

H-Index - 7

eISSN - 1740-1194

pISSN - 0954-982X

DOI - 10.1042/bio03801022

Subject(s) - medicine , diabetes mellitus , disease , kidney disease , intensive care medicine , clinical practice , adverse effect , physical therapy , endocrinology

A key element in the management of patients with chronic diseases is the prevention of complications. In patients with diabetes mellitus, diabetic kidney disease (DKD) is among the most dangerous complications. Approaches to prevent or at least delay the onset and progression of DKD are widely used in clinical practice, but are associated with adverse effects in some patients. In this article we use the example of DKD to describe how the concept of “Personalized Medicine” can be applied to chronic diseases and preventative medicine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research